Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. [electronic resource]
- Journal of investigative medicine : the official publication of the American Federation for Clinical Research Apr 2015
- 626-31 p. digital
Publication Type: Journal Article
1708-8267
10.1097/JIM.0000000000000158 doi
Aged Biomarkers--blood Case-Control Studies Chemokine CX3CL1--blood Female Humans Male Middle Aged Osteoarthritis, Knee--blood Severity of Illness Index Synovial Fluid--metabolism